The alleviation of cerebral infarction by rh‐B4galt1 treatment was inhibited by TAZ siRNA and ML385 (Figure 5E,F), suggesting they could reverse the protective effects of rh‐B4galt1. The gene discussed is B4GALT1; the disease is brain infarction.